91 results
Page 2 of 5
8-K
EX-99.1
2n7qn cbmck0br5xxm
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am
8-K
EX-99.1
qd1gt56x067slubv
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
EX-99.2
jgnxu4mpo dc4v9
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
EX-99.2
0wkhfipx
15 Nov 21
Regulation FD Disclosure
11:32am
8-K
EX-99.1
wabbw9 eb5ir
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.2
h8ku5wnkjd
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.1
fy0i9 xhs
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
EX-99.2
i1tlbfdgxu3 xo63agg
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
3dyqn ywt
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-99.2
pmhvi
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
8-K
EX-99.1
fsvm617t
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
424B5
ycr31xel
19 Mar 21
Prospectus supplement for primary offering
4:04pm